# VOZ Advisors

> VOZ Advisors is a privately held New York consultancy that helps pharmaceutical and biotechnology companies bring patients, care partners, advocacy organizations, and professional groups into decisions across the medicine lifecycle. Its work combines custom research, facilitation, strategy, implementation, and a proprietary subscription platform called LEAD, which contains more than 3,100 organizational profiles.

- **Founded:** 1995
- **Headquarters:** New York, United States
- **Founders:** Mark Krueger (Founder and former President)
- **Products:** Strategic plan development, LEAD, Patient experience mapping, Advocacy relations benchmarking, Stakeholder forums
- **Notable:** Operating since 1995 and active under the VOZ Advisors name since a 2018 rebrand from MK&A., Built LEAD to more than 3,100 organizational profiles across nine focus areas and 30-plus categories., Reports having planned and facilitated hundreds of advisory boards, listening tours, and roundtables.

## Products & services

- **Strategic plan development** — Research-based advocacy and engagement roadmaps tied to business, clinical, and regulatory milestones.
- **LEAD** — A proprietary subscription platform with more than 3,100 profiles of patient, professional, and multi-stakeholder organizations, organized across nine focus areas and more than 30 categories.
- **Patient experience mapping** — Qualitative mapping from first symptoms through diagnosis, treatment, trial participation, access, family impact, and decision-making.
- **Advocacy relations benchmarking** — Interviews and assessment of how a company is perceived by patient groups, professional societies, and advocates compared with peers or milestones.
- **Stakeholder forums** — Design and facilitation of advisory boards, listening tours, roundtables, co-creation workshops, and coalitions.
- **Internal readiness** — Audits, training, operating models, policies, SOPs, workshops, KPIs, and implementation support for patient advocacy functions.
- **Pre-approval access strategy** — Ethical policy design, training, testing, and implementation for access to investigational medicines.
- **Health equity strategy** — Research and partnership design intended to make engagement more representative and responsive to underserved communities.

## Achievements

- Operating since 1995 and active under the VOZ Advisors name since a 2018 rebrand from MK&A.
- Built LEAD to more than 3,100 organizational profiles across nine focus areas and 30-plus categories.
- Reports having planned and facilitated hundreds of advisory boards, listening tours, and roundtables.
- A two-year breast-cancer advocacy engagement helped a client's clinical trials reach full accrual within one year.
- A European patient-choice program secured professional-society endorsements and launched a policy brief in the European Parliament.
- Listed 37 employees and roughly 4,100 LinkedIn followers in September 2026.

## Latest updates

- **2026-09** — VOZ announced Helen McAneny Klein as Senior Vice President, Finance & Operations and Megan N. Freeland as Director, Client Services.
- **2026-08** — Entrepreneur in Residence Yann Le Cam was scheduled to speak on rare-disease policy at the second RAREMED Colombia Congress.
- **2026-07** — VOZ highlighted its work supporting the launch of MECP2 Duplication Global, an alliance of five international charities.
- **2026-05** — VOZ published a first-person account on how living with lupus shaped advocacy and purpose.
- **2026-03** — VOZ and BRIDGE convened a webinar on the chronic-disease evidence gap in pregnancy and breastfeeding.

## Links

- Website: https://vozadvisors.com
- LinkedIn: https://www.linkedin.com/company/vozadvisors
- Twitter/X: https://twitter.com/vozadvisors
- YouTube: https://www.youtube.com/channel/UC0N0JNcuw0s5zotNMi62ogg
- Facebook: https://facebook.com/vozadvisors/

---

Profile page: https://yespress.io/voz-advisors
Published by YesPress — https://yespress.io
Last updated: 2026-09-21